Skip to main content

SLS

Stock
Health Care
Biotechnology

Performance overview

SLS Price
Price Chart

Forward-looking statistics

Beta
1.13
Risk
91.88%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

Company info

SectorHealth Care
IndustryBiotechnology
Employees17
Market cap$83.7M

Fundamentals

Enterprise value$191.0M
Revenue$0.0
Revenue per employee
Profit margin0.00%
Debt to equity3.13

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$0.36
Dividend per share
Revenue per share$0.00
Avg trading volume (30 day)$5M
Avg trading volume (10 day)$7M
Put-call ratio

Macro factor sensitivity

Growth+1.4
Credit+6.8
Liquidity-0.9
Inflation-4.4
Commodities+2.2
Interest Rates-2.0

Valuation

Dividend yield0.00%
PEG Ratio-5.05
Price to sales
P/E Ratio-5.05
Enterprise Value to Revenue
Price to book7.11

Upcoming events

Next earnings dayMay 14, 2025
Next dividend day
Ex. dividend day

News

Galena Biopharma (SLS) Upgraded to Buy: What Does It Mean for the Stock?

Galena Biopharma (SLS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Investment Research (June 23, 2025)
Top 5 Health Care Stocks That Preparing To Pump This Quarter - Enovis (NYSE:ENOV), Esperion Therapeutics (NASDAQ:ESPR)

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Benzinga (March 29, 2023)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free